Spring 2021: BSG Completes Another Successful Executive Search— General Manager, Hamilton Thorne
BSG proudly announces a recently completed executive placement. Brett Fulton formally accepted the position as the General Manager at Hamilton Thorne.
Brett Fulton joins Hamilton Thorne as an experienced GM and successful commercial leader. He brings to Hamilton Thorne extensive global leadership experience in medical devices and a proven track record in driving innovation and creating exceptional value for customers. Brett has earned the reputation of a highly effective people leader with a well-established ability to unlock the potential of teams and build award-winning cultures.
Brett was most recently Vice President of Sales & Marketing of Microline Surgical, a manufacturer of surgical devices. Earlier, he was General Manager of Stryker’s Medical Division in Asia & South Pacific, a role he assumed upon Stryker’s acquisition of Gaymar Industries. Brett’s early career includes progressive marketing, business development, and sales roles at Bristol Myers Squibb and Abbott Diagnostics. Brett holds a B.Sc. in Life Sciences from the University of Cape Town.
About Hamilton Thorne:
Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced image analysis systems for the fertility, stem cell and development biology research markets.
Its novel solutions reduce cost, increase productivity, improve results and enable research breakthroughs in regenerative medicine, stem cell research, and its core fertility markets.
Hamilton Thorne's laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF (In Vitro Fertilization) procedures. Currently the Company has five lasers that have been introduced, with additional products in development. Each member of the laser family is built on the same architecture, but serves different market applications.
Hamilton Thorne’s CASA (Computer Assisted Sperm Analysis) image analysis systems are designed to bring quality, efficiency and reliability to studies of reproductive cells in the human fertility, animal sciences and reproductive toxicology fields. These systems assist researchers and clinicians in analyzing sperm motility and other characteristics in human fertility, toxicology and animal applications. In 2012, the Company began a significant investment in additional hardware and software capabilities across this product line and began to rollout the next generation of these devices in the third quarter of 2012.
The Company's novel laser systems are a standard in IVF clinics and are rapidly emerging as the dominant products to facilitate precise micro-surgical procedures with stem cells and other living cells in the laboratory. Specific applications include the reducing time in developing transgenic animal models, dramatic reductions in cell damage during micro-surgical procedures and higher yields for many cell procedures.
“With the XYClone, I have been able to take a process that took months and reduce it to days" Kathy Mohr, University of North Carolina, Transgenic Resource Center.
Hamilton Thorne’s growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge.
For assistance with your next executive search, in the Manufacturing sector or across our array of practice area specialties, contact us today.
